Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey
Abstract Background People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepa...
Saved in:
Main Authors: | Andrew Scheibe (Author), Katherine Young (Author), Lorraine Moses (Author), Rudolph L. Basson (Author), Anna Versfeld (Author), C. Wendy Spearman (Author), Mark W. Sonderup (Author), Nishi Prabdial-Sing (Author), Jack Manamela (Author), Adrian J. Puren (Author), Kevin Rebe (Author), Harry Hausler (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities
by: Anna Versfeld, et al.
Published: (2020) -
Exploring the knowledge, attitudes and practices (KAP) of health care professionals on viral hepatitis notification in Gauteng, South Africa, 2015
by: Eva D. Mathatha, et al.
Published: (2018) -
Hepatitis B infection status among South Africans attending public health facilities over a five-year period: 2015 to 2019.
by: Shelina Moonsamy, et al.
Published: (2023) -
Hepatitis B infection status among South Africans attending public health facilities over a five-year period: 2015 to 2019
by: Shelina Moonsamy, et al.
Published: (2023) -
Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019
by: Shelina Moonsamy, et al.
Published: (2022)